Journal article
Factor VIII concentrate for hemophilia: comparison of two heat-treated products.
Abstract
In a controlled trial of heat-treated factor VIII concentrate from Cutter Laboratories and from Connaught Laboratories Limited, 25 patients with hemophilia received Cutter factor VIII and 24 patients with hemophilia received Connaught factor VIII. The mean increase in factor VIII level was similar for the two products (1.88% and 1.98% per unit/kg of body weight respectively [p greater than 0.1], or 89% and 95% respectively of the expected …
Authors
Walker IR; Pai MK; Blair BA; Johnston MA; Birkett NJ; Ofosu FA; Naylor DH
Journal
Canadian Medical Association Journal, Vol. 136, No. 2, pp. 150–152
Publication Date
January 15, 1987
ISSN
0820-3946